Je was op zoek naar: characteristics (Frans - Deens)

characteristics
egenskaber

characteristics and objectives
3. characteristics and objectives

summary of product characteristics (spc)
summary of product characteristics (spc)

budgetary characteristics ( add rows if necessary ) :
budgetary characteristics ( add rows if necessary) :

annex 2 - list of relevant changeover characteristics
annex 2 – list of relevant changeover characteristics

characteristics and objectives details of the context of the proposal are required in the explanatory memorandum .
characteristics and objectives details of the context of the proposal are required in the explanatory memorandum .

budget characteristics type of expenditure new efta contribution yes contributions form applicant countries yes heading in financial perspective no 3 internal policies
k , hovedgr . 72 hovedafd .

titre du document antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy
titel på dokumentet antimicrobials for general use in target animal species summary of product characteristics for antimicrobial products efficacy requirements for ectoparasiticides for cattle fluid therapy

budgetary characteristics ( add rows if necessary ) : type of expenditure new efta contribution contributions from applicant countries heading in financial perspective no 3
budgetary characteristics ( add rows if necessary ) : type of expenditure new efta contribution contributions from applicant countries heading in financial perspective no 3

prospective planning of pharmacovigilance notice to applicants – guideline on the summary of product characteristics (ec december 1999 – revised version)
prospective planning of pharmacovigilance notice to applicants – guideline on the summary of product characteristics (ec december 1999 – revised version)

budgetary characteristics ( add rows if necessary ) : n / a budget line type of expenditure new efta contribution contributions from applicant countries heading in financial perspective
budgetary characteristics ( add rows if necessary ) : n / a budget line type of expenditure new efta contribution contributions from applicant countries heading in financial perspective

core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti-d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)
core summary of product characteristics for hepatitis b immunoglobulin revision of core summary of product characteristics for human normal immunoglobulin for intravenous use – addition of indication for treatment of parvovirus b19 infection revision of core summary of product characteristics for human plasma derived factor vii products and human plasma prothrombin complex revision of core summary of product characteristics for factor viii inhibitor bypassing fraction warning on transmissible agents for patient leaflets and summary of product characteristics revision of core summary of product characteristics for human anti- d immunoglobulin for intravenous and/ or intramuscular use (cpmp/ bpwg/ 574/ 99)